Department: Barts Cancer InstituteSalary: £41,386 - £43,592 per annum (Grade 5)Reference: QMUL32768Location: Charterhouse SquareDate posted: 12 May 2023Closing date: 9 June 2023
Further details and apply
About the Role
Dr John Riches is seeking a talented and motivated postdoctoral research scientist to understand the interaction between metabolism and epigenetics in lymphoma biology. This project will use a variety of proteomic and metabolomic techniques to investigate the impact of inhibiting metabolism on epigenetics in lymphoma cell lines and primary human cells. In addition, a component of the work will involve the use of murine models of high grade lymphoma with the aim of providing pre-clinical evidence to support the development of metabolic inhibitors as novel treatments for lymphoma, alone or in combination with existing epigenetic therapies.
About You
This project would be suitable for an individual with a PhD in immunology, cell biology, metabolism or related area. Candidates should have expertise in a range of cell biology and molecular techniques, including primary cell isolation/characterisation/culture, flow cytometry and cell sorting, western blotting, metabolomics, immunohistochemistry and murine work.
About the School/Department/Institute/Project
The Barts Cancer Institute (BCI) is a Cancer Research UK Centre of Excellence whose work aims to transform the lives of those with and at risk of cancer through innovative research in the laboratory, in patients and in populations. It is one of six institutes within The Faculty of Medicine and Dentistry (FMD) BCI is internationally renowned in many areas of cancer research and it combines ground-breaking basic research with the expertise of clinicians and clinician scientists from the Centre for Experimental Cancer Medicine and the Barts NHS Trust to achieve improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics. BCI is committed in supporting and developing future cancer researchers through its extensive postgraduate training
About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable. Throughout our history, we have fostered social justice and improved lives through academic excellence.
Benefits
We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities including an on-site nursery at the Mile End campus.
The post is based at Barts Cancer Institute in London. It is full time (35 hours per week), fixed term appointment for 3 years, with an expected start date of 1st June 2023. The starting salary will be Grade 5, in the range of £41,386 - £43,592 per annum.
Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.
Informal enquiries should be addressed to John Riches at j.riches@qmul.ac.uk or on +44 (0) 020 7882 3825.
The closing date for applications is 9 June 2023
Interviews are expected to be held shortly thereafter.
Valuing Diversity & Committed to Equality